Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Pain
4-OHT gel reduces cyclic breast pain among premenopausal women, study shows
December 30th, 2004
Ascend Therapeutics announced that its investigational transdermal 4-OHT gel reduced cyclic breast pain among premenopausal women, based on preliminary results obtained from a phase II clinical study. ASCEND's study, which evaluated 4-OHT gel's safety and efficacy in treating cyclic mastalgia, was conducted in the U.S. and Europe. The phase II randomized, double-blind, dose-ranging, placebo-controlled trial included 130 premenopausal women who had at least a 4-month history of symptomatic breast pain. Transdermal administration of a 4-mg dose of 4-OHT gel to the breast yielded a statistically significant decrease in an objective...
Source: Women's Health Weekly (2004-12-30)
|
